4 Results for "

Indirubin-3'-monoxime

" in MedChemExpress (MCE) Product Catalog:
Products (4)

4 Results for "Indirubin-3'-monoxime" in MCE Product Catalog:

4
4 Cited Publications
Cat. No.: HY-19807
CAS No.: 160807-49-8
Synonyms: Indirubin-3'-oxime
Target:  

GSK-3 CDK Lipoxygenase

Research Areas:  

Cancer

Indirubin-3'-monoxime is a potent GSK-3β inhibitor, and weakly inhibits 5-Lipoxygenase, with IC50s of 22 nM and 7.8-10 µM, respectively; Indirubin-3'-monoxime also shows inhibitory activities against CDK5/p25 and CDK1/cyclin B, with IC50s of 100 and 180 nM.
loading...
    loading...
Cat. No.: HY-111930
CAS No.: 331467-03-9
Purity:  99.50%
Target:  

GSK-3 CDK

Research Areas:  

Cancer

5-Iodo-indirubin-3'-monoxime is a potent GSK-3β, CDK5/P25 and CDK1/cyclin B inhibitor, competing with ATP for binding to the catalytic site of the kinase, with IC50s of 9, 20 and 25 nM, respectively .
loading...
    loading...
Cat. No.: HY-111931
CAS No.: 331467-05-1
Target:  

CDK GSK-3

Research Areas:  

Cancer

Indirubin-3'-monoxime-5-sulphonic acid is a potent and selective inhibitor of CDK1, CDK5, and GSK-3β with IC50s of 5 nM, 7 nM, and 80 nM, respectively .
loading...
    loading...
Cat. No.: HY-111930R
CAS No.: 331467-03-9
Research Areas:  

Cancer

5-Iodo-indirubin-3'-monoxime (Standard) is the analytical standard of 5-Iodo-indirubin-3'-monoxime (HY-111930). This product is intended for research and analytical applications. 5-Iodo-indirubin-3'-monoxime is a potent GSK-3β, CDK5/P25 and CDK1/cyclin B inhibitor, competing with ATP for binding to the catalytic site of the Kinase, with IC50s of 9, 20 and 25 nM, respectively .
loading...
    loading...